Washington Biotechnology, Inc. |
_____________________________________
Innovation . Speed . Accuracy . Dependability __________________________________________
EAE Models: Multiple Sclerosis
Washington Biotechnology, Inc., a leader in In Vivo preclinical testing, has full services for analysis of test article efficacy in EAE Models of human multiple sclerosis (human demyelinating disease).
Our comprehensive services include:
- Models for Chronic Progressive MS (EAE MOG peptide-induced disease) and Remitting, Relapsing MS (EAE PLP peptide-induced disease).
- Prophylactic and Therapeutic Protocols
- Daily In Vivo Scoring and animal observations (results transmitted frequently so you see how your study is progressing)
- Assessment of Spinal Cords for demyelination and inflammation
- Validated Controls: FTY720 and Dexamethasone
- Experienced technical staff
- Rapid Scheduling: your study will start within 10 days of order
- Detailed and Comprehensive Final Reports
-
Our technical staff is available to discuss your requirements and design a cost-beneficial study plan to best fit your drug development and budget parameters.
For further information on our EAE models and to receive expert recommendations on your intended study, please contact us.
|